Category: neuroendocrine cancer

CNETS Halifax 2011 Conference

CNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals

April 1, 2011

Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…

READ MORE
FDA logo

Carcinoid Cancer Foundation to Speak on Behalf of NET Cancer Patients at April 12, 2011 FDA Oncologic Drugs Advisory Committee Meeting

March 24, 2011

Grace Goldstein, Chief Operating Officer of the Carcinoid Cancer Foundation, will speak at the Open Public Hearing segment during the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee Meeting on April 12, 2011 in Silver …

READ MORE
GlucoMedix

RadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients

March 23, 2011

Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund.  According to Ebrahim

READ MORE
_DSC2397 copyW_OutshadowSharp

Carcinoid Cancer Foundation Symposium Features Leading NET Cancer Specialists & a Patient Panel

March 5, 2011

What are the most state-of-the-art treatments for carcinoid and NET cancer patients today?  Join us on May 1st when the Carcinoid Cancer Foundation presents its 14th Annual Symposium, “Neuroendocrine Tumor Management: The Era of Personalized

READ MORE
Simron Singh, MD

Carcinoid Cancer Foundation Thanks Steve Jobs for Bringing about Greater Awareness of Neuroendocrine Cancers

January 28, 2011

Since the announcement was made earlier this month that Apple’s CEO Steve Jobs would be taking a medical leave of absence there has been significant media coverage about pancreatic neuroendocrine tumors, NET cancer, and carcinoid.  Although…

READ MORE
Rare Disease Day Partner

Carcinoid Cancer Foundation Asks You to Help Support Rare Disease Day: Write Your Reps Campaign

January 19, 2011

Carcinoid patients, physicians, family, friends and colleagues can help support Rare Disease Day 2011 by participating in NORD’s Write Your Reps CampaignNORD (National Organization for Rare Diseases) and its advocacy partners have worked with…

READ MORE

Fortune Reports That Steve Jobs Sought Neuroendocrine Cancer Treatment in Switzerland

January 18, 2011

Fortune reported today, January 18, 2011, that Apple’s CEO Steve Jobs went to Basel, Switzerland in 2009 seeking treatment for neuroendocrine cancer. Read the story HERE.…

READ MORE
Steve Jobs Talks about Liver Transplant

Steve Jobs to Take New Medical Leave from Apple

January 17, 2011

Steve Jobs, CEO and co-founder of Apple and the most well-known member of the carcinoid and neuroendocrine tumor community, is taking a new medical leave of absence.  This announcement was reported today, January 17, 2011, by The New York Times, a year…

READ MORE
ASCO Calendar 2011

Carcinoid Cancer Featured in ASCO 2011 Expressions of Hope Calendar

January 17, 2011

Carcinoid cancer is the focus of the April calendar page for the 2011 Expressions of Hope calendar published by the ASCO (American Society of Clinical Oncology) Cancer Foundation. The calendar illustrations have been created by cancer patients, family…

READ MORE
CNETS 2010 Conference

Videos from 2010 Vancouver International Carcinoid & NET Cancer Conference Now Online

January 5, 2011

Maureen Coleman, President of CNETS Canada, has announced that videos from the May 2010 international carcinoid and NET cancer conference for patients and medical professionals are now online at http://cnetscanada.org.  According to Ms. Coleman,…

READ MORE